<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Future HIV Therapy via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Future HIV Therapy' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Future+HIV+Therapy&t=Future+HIV+Therapy&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 13 Feb 2011 18:12:23 +0100</lastBuildDate>
        <item>
            <title>HIV Therapy merges with Future Virology</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.57?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 613-613. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260754</comments>
            <pubDate>Wed, 15 Dec 2010 04:00:28 +0100</pubDate>
            <guid isPermaLink="false">4260754</guid>        </item>
        <item>
            <title>Microbicides: where are we now and what next?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.50?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 615-618. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260755</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:53 +0100</pubDate>
            <guid isPermaLink="false">4260755</guid>        </item>
        <item>
            <title>Premature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virus</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.53?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 675-692. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260762</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:51 +0100</pubDate>
            <guid isPermaLink="false">4260762</guid>        </item>
        <item>
            <title>HIV-related lymphoma</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.54?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 649-659. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260760</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:51 +0100</pubDate>
            <guid isPermaLink="false">4260760</guid>        </item>
        <item>
            <title>Regulatory T cells in HIV immunotherapy</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.51?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 639-647. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260759</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:51 +0100</pubDate>
            <guid isPermaLink="false">4260759</guid>        </item>
        <item>
            <title>Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.52?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 713-722. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260764</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:50 +0100</pubDate>
            <guid isPermaLink="false">4260764</guid>        </item>
        <item>
            <title>The intersection between HIV and syphilis in men who have sex with men: some fresh perspectives</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.55?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 661-673. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260761</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:49 +0100</pubDate>
            <guid isPermaLink="false">4260761</guid>        </item>
        <item>
            <title>Cervical cancer prevention in HIV-infected women in resource-limited settings</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.58?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 625-628. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260757</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:49 +0100</pubDate>
            <guid isPermaLink="false">4260757</guid>        </item>
        <item>
            <title>Lymph node involution, T-cell adaptation and T-cell death in HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.56?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 629-637. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260758</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:48 +0100</pubDate>
            <guid isPermaLink="false">4260758</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.60?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 619-624. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260756</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:48 +0100</pubDate>
            <guid isPermaLink="false">4260756</guid>        </item>
        <item>
            <title>Switching antiretroviral therapy to minimize metabolic complications</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.47?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 693-711. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260763</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:47 +0100</pubDate>
            <guid isPermaLink="false">4260763</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.59?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2010, Vol. 4, No. 6, Pages 723-723. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260765</comments>
            <pubDate>Tue, 14 Dec 2010 14:14:45 +0100</pubDate>
            <guid isPermaLink="false">4260765</guid>        </item>
        <item>
            <title>HIV treatment in the criminal justice system</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.43?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 519-522. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111142</comments>
            <pubDate>Tue, 26 Oct 2010 03:00:59 +0100</pubDate>
            <guid isPermaLink="false">4111142</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.49?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 611-611. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111152</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:54 +0100</pubDate>
            <guid isPermaLink="false">4111152</guid>        </item>
        <item>
            <title>Politics and policy in HIV/AIDS: the road ahead for South Africa</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.34?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 527-530. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111144</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:54 +0100</pubDate>
            <guid isPermaLink="false">4111144</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.48?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 523-525. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111143</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:54 +0100</pubDate>
            <guid isPermaLink="false">4111143</guid>        </item>
        <item>
            <title>The impact of baseline characteristics on virologic response to etravirine: 48-week pooled analysis of DUET-1 and DUET-2</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.41?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 605-610. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111151</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:53 +0100</pubDate>
            <guid isPermaLink="false">4111151</guid>        </item>
        <item>
            <title>On the growing complexity of HIV-1 vaccines</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.40?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 543-552. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111146</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:53 +0100</pubDate>
            <guid isPermaLink="false">4111146</guid>        </item>
        <item>
            <title>Recent developments in HIV-related kidney disease</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.42?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 589-603. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111150</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:52 +0100</pubDate>
            <guid isPermaLink="false">4111150</guid>        </item>
        <item>
            <title>Noninfectious HIV-related comorbidities and HAART toxicities: choosing alternative antiretroviral strategies</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.44?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 553-565. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111147</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:51 +0100</pubDate>
            <guid isPermaLink="false">4111147</guid>        </item>
        <item>
            <title>Immune reconstitution inflammatory syndrome in HIV-positive patients: a relatively new and not fully understood phenomenon</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.45?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 577-587. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111149</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:49 +0100</pubDate>
            <guid isPermaLink="false">4111149</guid>        </item>
        <item>
            <title>HIV-related cryptococcal meningitis in resource-limited settings</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.46?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 567-576. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111148</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:48 +0100</pubDate>
            <guid isPermaLink="false">4111148</guid>        </item>
        <item>
            <title>Clinical use of raltegravir: a review</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.38?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2010, Vol. 4, No. 5, Pages 531-542. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111145</comments>
            <pubDate>Mon, 25 Oct 2010 16:02:46 +0100</pubDate>
            <guid isPermaLink="false">4111145</guid>        </item>
        <item>
            <title>Origin of HIV/AIDS and risk for ongoing zoonotic transmissions from nonhuman primates to humans</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.33?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 387-390. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731366</comments>
            <pubDate>Thu, 08 Jul 2010 03:00:40 +0100</pubDate>
            <guid isPermaLink="false">3731366</guid>        </item>
        <item>
            <title>HIV treatment in US prisons</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.35?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 505-510. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731374</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:17 +0100</pubDate>
            <guid isPermaLink="false">3731374</guid>        </item>
        <item>
            <title>Micronutrients and HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.36?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 437-469. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731371</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:16 +0100</pubDate>
            <guid isPermaLink="false">3731371</guid>        </item>
        <item>
            <title>Effect of maternal HIV infection on measles susceptibility during early infancy: implications for optimizing protection of the infant</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.31?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 471-482. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731372</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:15 +0100</pubDate>
            <guid isPermaLink="false">3731372</guid>        </item>
        <item>
            <title>HIV gene therapy that’s not a SIN</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.32?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 395-398. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731368</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:14 +0100</pubDate>
            <guid isPermaLink="false">3731368</guid>        </item>
        <item>
            <title>Treatment and prevention of cytomegalovirus-associated diseases in HIV-1 infection in the era of HAART</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.30?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 413-436. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731370</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:13 +0100</pubDate>
            <guid isPermaLink="false">3731370</guid>        </item>
        <item>
            <title>HIV diagnostics: challenges and opportunities</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.29?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 399-412. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731369</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:01 +0100</pubDate>
            <guid isPermaLink="false">3731369</guid>        </item>
        <item>
            <title>Innate immune natural killer cells and their role in HIV and SIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.28?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 483-504. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731373</comments>
            <pubDate>Wed, 07 Jul 2010 13:09:00 +0100</pubDate>
            <guid isPermaLink="false">3731373</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.37?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 391-393. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731367</comments>
            <pubDate>Wed, 07 Jul 2010 13:08:59 +0100</pubDate>
            <guid isPermaLink="false">3731367</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.39?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2010, Vol. 4, No. 4, Pages 517-517. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3731375</comments>
            <pubDate>Wed, 07 Jul 2010 13:08:58 +0100</pubDate>
            <guid isPermaLink="false">3731375</guid>        </item>
        <item>
            <title>Neurocognitive disorders during antiretroviral treatment, despite full HIV RNA suppression</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.24?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 257-260. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531824</comments>
            <pubDate>Wed, 05 May 2010 03:00:53 +0100</pubDate>
            <guid isPermaLink="false">3531824</guid>        </item>
        <item>
            <title>Dual infection with HIV-1 and HIV-2: double trouble or destructive interference?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.26?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 305-323. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531831</comments>
            <pubDate>Tue, 04 May 2010 14:03:47 +0100</pubDate>
            <guid isPermaLink="false">3531831</guid>        </item>
        <item>
            <title>Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.23?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 371-379. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531835</comments>
            <pubDate>Tue, 04 May 2010 14:03:46 +0100</pubDate>
            <guid isPermaLink="false">3531835</guid>        </item>
        <item>
            <title>8th European HIV Drug Resistance Workshop</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.22?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 285-287. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531828</comments>
            <pubDate>Tue, 04 May 2010 14:03:46 +0100</pubDate>
            <guid isPermaLink="false">3531828</guid>        </item>
        <item>
            <title>Possible applications for replicating HIV-1 vectors</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.20?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 361-369. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531834</comments>
            <pubDate>Tue, 04 May 2010 14:03:44 +0100</pubDate>
            <guid isPermaLink="false">3531834</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.25?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 261-263. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531825</comments>
            <pubDate>Tue, 04 May 2010 14:03:44 +0100</pubDate>
            <guid isPermaLink="false">3531825</guid>        </item>
        <item>
            <title>Insights into the functions of a molecular Swiss army knife: the intasome structure reveals inhibitor action</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.21?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 289-291. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531829</comments>
            <pubDate>Tue, 04 May 2010 14:03:43 +0100</pubDate>
            <guid isPermaLink="false">3531829</guid>        </item>
        <item>
            <title>The DUET trials: etravirine in the management of treatment-experienced HIV-1-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.14?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 265-280. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531826</comments>
            <pubDate>Tue, 04 May 2010 14:03:41 +0100</pubDate>
            <guid isPermaLink="false">3531826</guid>        </item>
        <item>
            <title>Tenofovir disoproxil fumarate and the kidney in HIV-infected patients: the evidence thus far</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.16?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 345-359. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531833</comments>
            <pubDate>Tue, 04 May 2010 14:03:39 +0100</pubDate>
            <guid isPermaLink="false">3531833</guid>        </item>
        <item>
            <title>Genotypic determination of HIV-1 tropism in the clinical setting</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.15?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 293-303. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531830</comments>
            <pubDate>Tue, 04 May 2010 14:03:38 +0100</pubDate>
            <guid isPermaLink="false">3531830</guid>        </item>
        <item>
            <title>Management of oropharyngeal and esophageal candidiasis in patients with HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.18?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 325-343. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531832</comments>
            <pubDate>Tue, 04 May 2010 14:03:36 +0100</pubDate>
            <guid isPermaLink="false">3531832</guid>        </item>
        <item>
            <title>Rituximab therapy for HIV-associated multicentric Castleman disease</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.17?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , May 2010, Vol. 4, No. 3, Pages 281-284. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3531827</comments>
            <pubDate>Tue, 04 May 2010 14:03:33 +0100</pubDate>
            <guid isPermaLink="false">3531827</guid>        </item>
        <item>
            <title>Genetic vaccination: engineering antiviral T-cell immunity through stem cells</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.9?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 123-126. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352018</comments>
            <pubDate>Thu, 11 Mar 2010 04:00:34 +0100</pubDate>
            <guid isPermaLink="false">3352018</guid>        </item>
        <item>
            <title>Treatment considerations for psychiatric syndromes associated with HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.12?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 231-245. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352028</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:40 +0100</pubDate>
            <guid isPermaLink="false">3352028</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.11?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 131-133. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352020</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:38 +0100</pubDate>
            <guid isPermaLink="false">3352020</guid>        </item>
        <item>
            <title>HIV-associated chronic immune activation: current understandings and therapeutic intervention</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.2?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 161-177. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352024</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:35 +0100</pubDate>
            <guid isPermaLink="false">3352024</guid>        </item>
        <item>
            <title>The nucleocapsid protein of HIV-1 as a promising therapeutic target for antiviral drugs</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.3?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 179-198. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352025</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:33 +0100</pubDate>
            <guid isPermaLink="false">3352025</guid>        </item>
        <item>
            <title>Polygyny, concurrency, its impact and lack of impact on HIV</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.10?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 139-144. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352022</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:31 +0100</pubDate>
            <guid isPermaLink="false">3352022</guid>        </item>
        <item>
            <title>Lessons from viral latency in T cells: manipulating HIV-1 transcription by siRNA</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.1?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 199-213. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352026</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:29 +0100</pubDate>
            <guid isPermaLink="false">3352026</guid>        </item>
        <item>
            <title>Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.6?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 145-160. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352023</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:26 +0100</pubDate>
            <guid isPermaLink="false">3352023</guid>        </item>
        <item>
            <title>Prevention of mother-to-child HIV transmission in South Africa: the dawning of a new era</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.7?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 127-130. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352019</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:24 +0100</pubDate>
            <guid isPermaLink="false">3352019</guid>        </item>
        <item>
            <title>Psychiatric illness, access and adherence to HAART: a brief review of recent findings and implications for care</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.4?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 215-230. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352027</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:23 +0100</pubDate>
            <guid isPermaLink="false">3352027</guid>        </item>
        <item>
            <title>Measurement of antiretroviral drugs in the lungs of HIV-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.5?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 247-251. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352029</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:21 +0100</pubDate>
            <guid isPermaLink="false">3352029</guid>        </item>
        <item>
            <title>The 13th Bangkok International Symposium on HIV Medicine</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.10.8?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , March 2010, Vol. 4, No. 2, Pages 135-137. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3352021</comments>
            <pubDate>Wed, 10 Mar 2010 14:29:20 +0100</pubDate>
            <guid isPermaLink="false">3352021</guid>        </item>
        <item>
            <title>Indian manufacture of new generic antiretrovirals: implications for global access to anti-HIV drugs</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.55?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 1-4. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112883</comments>
            <pubDate>Tue, 22 Dec 2009 15:29:59 +0100</pubDate>
            <guid isPermaLink="false">3112883</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.60?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 121-121. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112894</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:18 +0100</pubDate>
            <guid isPermaLink="false">3112894</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.61?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 5-7. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112884</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:16 +0100</pubDate>
            <guid isPermaLink="false">3112884</guid>        </item>
        <item>
            <title>T-cell dysfunction in HIV-1 infection: targeting the inhibitors</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.51?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 83-99. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112892</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:14 +0100</pubDate>
            <guid isPermaLink="false">3112892</guid>        </item>
        <item>
            <title>Yellow fever vaccination in HIV-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.52?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 17-26. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112887</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:11 +0100</pubDate>
            <guid isPermaLink="false">3112887</guid>        </item>
        <item>
            <title>Strategies and approaches to purge the latent reservoir of HIV</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.50?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 55-63. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112890</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:08 +0100</pubDate>
            <guid isPermaLink="false">3112890</guid>        </item>
        <item>
            <title>Protein arginine methylation: a pivotal factor and a target for novel HIV-therapeutics, other viruses and multiple diseases</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.56?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 65-81. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112891</comments>
            <pubDate>Tue, 22 Dec 2009 14:37:04 +0100</pubDate>
            <guid isPermaLink="false">3112891</guid>        </item>
        <item>
            <title>At the forefront of retrovirology research: Frontiers of Retrovirology</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.54?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 13-15. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112886</comments>
            <pubDate>Tue, 22 Dec 2009 14:36:56 +0100</pubDate>
            <guid isPermaLink="false">3112886</guid>        </item>
        <item>
            <title>Obstructive lung disease and HIV/AIDS in the HAART era</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.53?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 41-54. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112889</comments>
            <pubDate>Tue, 22 Dec 2009 14:36:53 +0100</pubDate>
            <guid isPermaLink="false">3112889</guid>        </item>
        <item>
            <title>Australasian HIV/AIDS Conference 2009</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.59?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 9-11. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112885</comments>
            <pubDate>Tue, 22 Dec 2009 14:36:51 +0100</pubDate>
            <guid isPermaLink="false">3112885</guid>        </item>
        <item>
            <title>Role of the CD4 count in HIV management</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.58?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 27-39. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112888</comments>
            <pubDate>Tue, 22 Dec 2009 14:36:48 +0100</pubDate>
            <guid isPermaLink="false">3112888</guid>        </item>
        <item>
            <title>MHC-I-restricted HIV epitope processing, immune control and immunogen design</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.57?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , January 2010, Vol. 4, No. 1, Pages 101-117. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112893</comments>
            <pubDate>Tue, 22 Dec 2009 14:36:45 +0100</pubDate>
            <guid isPermaLink="false">3112893</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.48?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 549-551. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3035146</comments>
            <pubDate>Fri, 27 Nov 2009 15:19:04 +0100</pubDate>
            <guid isPermaLink="false">3035146</guid>        </item>
        <item>
            <title>Impact of the global economic crisis on antiretroviral treatment programs</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.45?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 545-548. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945393</comments>
            <pubDate>Fri, 30 Oct 2009 16:03:15 +0100</pubDate>
            <guid isPermaLink="false">2945393</guid>        </item>
        <item>
            <title>The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.40?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 583-594. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945398</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:38 +0100</pubDate>
            <guid isPermaLink="false">2945398</guid>        </item>
        <item>
            <title>Antiretroviral therapy in Malaysia: identifying barriers to universal access</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.41?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 573-582. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945397</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:36 +0100</pubDate>
            <guid isPermaLink="false">2945397</guid>        </item>
        <item>
            <title>HIV infection: just an infectious disease?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.47?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 553-555. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945394</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:34 +0100</pubDate>
            <guid isPermaLink="false">2945394</guid>        </item>
        <item>
            <title>How sweet it is? Susceptibility to diabetes mellitus in HIV-1 treatment</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.46?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 613-624. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945400</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:33 +0100</pubDate>
            <guid isPermaLink="false">2945400</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.49?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 647-647. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945403</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:31 +0100</pubDate>
            <guid isPermaLink="false">2945403</guid>        </item>
        <item>
            <title>Severe acute malnutrition and HIV in African children</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.43?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 595-611. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945399</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:29 +0100</pubDate>
            <guid isPermaLink="false">2945399</guid>        </item>
        <item>
            <title>Pharmacokinetics of HIV non-nucleoside reverse-transcriptase inhibitors</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.42?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 625-632. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945401</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:27 +0100</pubDate>
            <guid isPermaLink="false">2945401</guid>        </item>
        <item>
            <title>Secondary structure of the HIV-1 genome</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.44?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 557-563. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945395</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:24 +0100</pubDate>
            <guid isPermaLink="false">2945395</guid>        </item>
        <item>
            <title>Designing immunity to HIV: manipulating antibody-dependent cellular cytotoxicity antibodies</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.37?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 633-640. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945402</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:22 +0100</pubDate>
            <guid isPermaLink="false">2945402</guid>        </item>
        <item>
            <title>Vaccination of HIV-infected adults</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.39?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , November 2009, Vol. 3, No. 6, Pages 565-572. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945396</comments>
            <pubDate>Fri, 30 Oct 2009 15:43:14 +0100</pubDate>
            <guid isPermaLink="false">2945396</guid>        </item>
        <item>
            <title>Management of late presentation in HIV: what the data tell us</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.32?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 423-426. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773465</comments>
            <pubDate>Tue, 08 Sep 2009 08:39:16 +0100</pubDate>
            <guid isPermaLink="false">2773465</guid>        </item>
        <item>
            <title>HAART for children with treatment failure</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.28?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 485-499. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773471</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:21 +0100</pubDate>
            <guid isPermaLink="false">2773471</guid>        </item>
        <item>
            <title>Transmitted drug resistance in nonsubtype B HIV-1 infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.30?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 447-465. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773469</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:20 +0100</pubDate>
            <guid isPermaLink="false">2773469</guid>        </item>
        <item>
            <title>HIV-1 nonsubtype B distribution across certain resource-rich countries</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.25?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 467-483. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773470</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:18 +0100</pubDate>
            <guid isPermaLink="false">2773470</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.38?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 543-543. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773474</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:17 +0100</pubDate>
            <guid isPermaLink="false">2773474</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.36?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 427-429. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773466</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:16 +0100</pubDate>
            <guid isPermaLink="false">2773466</guid>        </item>
        <item>
            <title>Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.35?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 501-526. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773472</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:15 +0100</pubDate>
            <guid isPermaLink="false">2773472</guid>        </item>
        <item>
            <title>Dendritic cell function in HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.34?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 527-537. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773473</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:14 +0100</pubDate>
            <guid isPermaLink="false">2773473</guid>        </item>
        <item>
            <title>Rethinking the role of the local community in HIV epidemic spread in sub-Saharan Africa: a proximate-determinants approach</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.33?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 435-445. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773468</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:13 +0100</pubDate>
            <guid isPermaLink="false">2773468</guid>        </item>
        <item>
            <title>5th European Conference on Clinical and Social Research on AIDS and Drugs</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.31?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , September 2009, Vol. 3, No. 5, Pages 431-433. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773467</comments>
            <pubDate>Tue, 08 Sep 2009 08:13:09 +0100</pubDate>
            <guid isPermaLink="false">2773467</guid>        </item>
        <item>
            <title>International and domestic funding for HIV research: how much and how is it spent?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.17?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 307-310. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586108</comments>
            <pubDate>Mon, 06 Jul 2009 16:59:25 +0100</pubDate>
            <guid isPermaLink="false">2586108</guid>        </item>
        <item>
            <title>Managing HIV infection in infants, children and adolescents with HAART</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.18?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 391-404. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586118</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:41 +0100</pubDate>
            <guid isPermaLink="false">2586118</guid>        </item>
        <item>
            <title>Future directions in the treatment of HIV–HBV coinfection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.19?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 405-415. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586119</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:39 +0100</pubDate>
            <guid isPermaLink="false">2586119</guid>        </item>
        <item>
            <title>Clinical implications of antiretroviral pharmacokinetics and pharmacodynamics in the CNS</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.13?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 361-367. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586116</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:36 +0100</pubDate>
            <guid isPermaLink="false">2586116</guid>        </item>
        <item>
            <title>Future treatment for non-AIDS-defining cancers in HIV-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.14?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 311-314. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586109</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:34 +0100</pubDate>
            <guid isPermaLink="false">2586109</guid>        </item>
        <item>
            <title>Managing HIV therapy literacy in resource-limited settings</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.16?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 339-344. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586113</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:32 +0100</pubDate>
            <guid isPermaLink="false">2586113</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.27?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 421-421. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586120</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:21 +0100</pubDate>
            <guid isPermaLink="false">2586120</guid>        </item>
        <item>
            <title>Tesamorelin: a synthetic growth hormone-releasing factor analog for the treatment of HIV-associated lipodystrophy</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.24?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 319-327. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586111</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:16 +0100</pubDate>
            <guid isPermaLink="false">2586111</guid>        </item>
        <item>
            <title>Advances in HIV care and treatment in resource-poor countries</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.22?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 329-338. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586112</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:12 +0100</pubDate>
            <guid isPermaLink="false">2586112</guid>        </item>
        <item>
            <title>Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.23?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 369-390. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586117</comments>
            <pubDate>Mon, 06 Jul 2009 15:10:07 +0100</pubDate>
            <guid isPermaLink="false">2586117</guid>        </item>
        <item>
            <title>Clinical implications of new findings in HIV basic research</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.20?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 351-360. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586115</comments>
            <pubDate>Mon, 06 Jul 2009 15:09:58 +0100</pubDate>
            <guid isPermaLink="false">2586115</guid>        </item>
        <item>
            <title>Public–private partnerships and HIV vaccine research</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.21?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 345-349. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586114</comments>
            <pubDate>Mon, 06 Jul 2009 15:09:49 +0100</pubDate>
            <guid isPermaLink="false">2586114</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.11?ai=87e&amp;mi=0&amp;af=R</link>
            <description>HIV Therapy , July 2009, Vol. 3, No. 4, Pages 315-317. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2586110</comments>
            <pubDate>Thu, 30 Apr 2009 13:41:06 +0100</pubDate>
            <guid isPermaLink="false">2586110</guid>        </item>
        <item>
            <title>Are we ready for home-based, self-testing for HIV?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.515?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 515-520. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028269</comments>
            <pubDate>Thu, 11 Dec 2008 11:54:05 +0100</pubDate>
            <guid isPermaLink="false">2028269</guid>        </item>
        <item>
            <title>RNAi as a potential new therapy for HIV infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.567?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 567-577. 
		
	Controlling HIV infection continues to be a major clinical and scientific challenge. Despite the therapeutic benefits associated with HAART, the need for novel treatment approaches to combat HIV-1 remains. Effective inhibition of HIV-1 infection has been ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028274</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:08 +0100</pubDate>
            <guid isPermaLink="false">2028274</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.617?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 617-617. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028278</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:07 +0100</pubDate>
            <guid isPermaLink="false">2028278</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.521?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 521-523. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028270</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:07 +0100</pubDate>
            <guid isPermaLink="false">2028270</guid>        </item>
        <item>
            <title>Immunology of SIV infection in natural hosts: implications for HIV pathogenesis</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.603?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 603-611. 
		
	AIDS is one of the worst pathologies of our time. Unfortunately, and despite a very large number of studies, the mechanisms of HIV pathogenesis in humans are still poorly understood. Nonpathogenic SIV infection of African nonhuman primates represents a ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028277</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:06 +0100</pubDate>
            <guid isPermaLink="false">2028277</guid>        </item>
        <item>
            <title>Drug resistance differences among HIV types and subtypes: a growing problem</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.579?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 579-593. 
		
	Although HIV-1 subtype B accounts for only 10% of worldwide HIV infections, almost all knowledge regarding antiretroviral (ARV) drug development and viral resistance is based on this subtype. More recently, an increasing body of evidence suggests that ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028275</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:06 +0100</pubDate>
            <guid isPermaLink="false">2028275</guid>        </item>
        <item>
            <title>Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.525?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 525-537. 
		
	Etravirine, a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), was approved in the USA in January, 2008, with approval in Europe expected later this year. It is dosed at 200 mg (two 100 mg tablets) twice daily foll owing a meal. ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028271</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:05 +0100</pubDate>
            <guid isPermaLink="false">2028271</guid>        </item>
        <item>
            <title>Proposed guidelines for the prevention of mother-to-child transmission of HIV in middle-income countries: the Thai Red Cross PMTCT guidelines</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.551?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 551-565. 
		
	The rate of perinatal HIV transmission has drastically decreased in high-income countries where interventions to reduce mother-to-child transmission of HIV have been successfully implemented. Guidelines for the prevention of mother-to-child transmission ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028273</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:04 +0100</pubDate>
            <guid isPermaLink="false">2028273</guid>        </item>
        <item>
            <title>Neurosyphilis in HIV-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.595?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 595-602. 
		
	Initial syphilis infection results in CNS invasion by the spirochete Treponema pallidum in approximately 25–30% of cases. Spontaneous CNS clearance can occur, and most patients do not develop neurosyphilis. However, neurosyphilis may be more commonly ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028276</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:03 +0100</pubDate>
            <guid isPermaLink="false">2028276</guid>        </item>
        <item>
            <title>Self-reported low physical function is associated with diabetes mellitus and insulin resistance in HIV-positive and HIV-negative men</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.6.539?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , November 2008, Vol. 2, No. 6, Pages 539-549. 
		
	 Aim: To investigate the association between self-reported physical function (as a surrogate for physical activity) and diabetes mellitus (DM) and insulin resistance (IR) among HIV-positive and -negative men. Method: A total of 384 HIV-negative and 274 ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2028272</comments>
            <pubDate>Thu, 11 Dec 2008 11:52:03 +0100</pubDate>
            <guid isPermaLink="false">2028272</guid>        </item>
        <item>
            <title>The number of HIV-infected individuals decreases by half in India: impact on the global epidemiology of HIV/AIDS</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.395?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 395-398. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810070</comments>
            <pubDate>Sat, 20 Sep 2008 03:00:08 +0100</pubDate>
            <guid isPermaLink="false">1810070</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.513?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 513-513. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810080</comments>
            <pubDate>Fri, 19 Sep 2008 15:42:02 +0100</pubDate>
            <guid isPermaLink="false">1810080</guid>        </item>
        <item>
            <title>Update on the development of HIV entry inhibitors</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.479?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 479-507. 
		
	 HIV fusion and entry are two steps in the viral lifecycle that can be targeted by several classes of antiviral drugs. The discovery of chemokines focused the attention on cellular co-receptors used by the virus for entering cells, and on the various ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810079</comments>
            <pubDate>Fri, 19 Sep 2008 15:42:02 +0100</pubDate>
            <guid isPermaLink="false">1810079</guid>        </item>
        <item>
            <title>Clinical significance of HIV-associated bone loss: when and how to intervene</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.465?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 465-478. 
		
	 Moderate decreases in bone mineral density (BMD) occur after initiation of several antiretroviral regimens. However, BMD appears to stabilize over time. Alendronate and zoledronate therapy decreases bone turnover markers and increases BMD in HIV-positive ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810078</comments>
            <pubDate>Fri, 19 Sep 2008 15:42:00 +0100</pubDate>
            <guid isPermaLink="false">1810078</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.407?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 407-409. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810072</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:59 +0100</pubDate>
            <guid isPermaLink="false">1810072</guid>        </item>
        <item>
            <title>Male circumcision is an efficacious, lasting and cost-effective strategy for combating HIV in high-prevalence AIDS epidemics</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.399?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 399-405. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810071</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:59 +0100</pubDate>
            <guid isPermaLink="false">1810071</guid>        </item>
        <item>
            <title>The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.437?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 437-451. 
		
	 Although sub-Saharan Africa contains approximately 12% of the world’s population, it hosts an estimated 68% of all living HIV-infected people (22.5 million persons) and 30% of annual cases of TB (4.4 million persons). In countries with an extended ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810076</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:58 +0100</pubDate>
            <guid isPermaLink="false">1810076</guid>        </item>
        <item>
            <title>Elvitegravir: an emerging HIV integrase inhibitor</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.411?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 411-418. 
		
	 Integration of the reverse transcribed HIV dsDNA into the host cell chromosome is critical for the subsequent production of progeny virions. In October 2007, the US FDA approved the first HIV-1 integrase inhibitor, raltegravir, as a therapeutic agent for ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810073</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:58 +0100</pubDate>
            <guid isPermaLink="false">1810073</guid>        </item>
        <item>
            <title>Virtual Physiological Human research initiative: the future for rational HIV treatment design?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.419?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 419-425. 
		
	 The clinical management of HIV-positive patients receiving existing drug regimens is performed largely as a clinician’s best guess, based on available viral and patient data. The development of new antiretroviral therapies for HIV is at an impasse. How ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810074</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:57 +0100</pubDate>
            <guid isPermaLink="false">1810074</guid>        </item>
        <item>
            <title>Prophylaxis and treatment of malaria in HIV-infected populations</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.453?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 453-464. 
		
	 Malaria and HIV infection are among the most important infectious diseases worldwide. Management of each infection may affect the other. Insecticide-impregnated bed nets and prophylaxis with trimethoprim–sulfamethoxazole have greatly reduced the ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810077</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:56 +0100</pubDate>
            <guid isPermaLink="false">1810077</guid>        </item>
        <item>
            <title>Unmet need and access to HIV services in Europe</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.5.427?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , September 2008, Vol. 2, No. 5, Pages 427-435. 
		
	 Responding effectively to unmet needs in testing, treatment and care for people infected with HIV is of critical importance in securing and maximizing individual and public health benefits across Europe. Ahead of a gathering of key European stakeholders ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810075</comments>
            <pubDate>Fri, 19 Sep 2008 15:41:56 +0100</pubDate>
            <guid isPermaLink="false">1810075</guid>        </item>
        <item>
            <title>Bigger is better: scaling-up antiretroviral policies in sub-Saharan Africa</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.297?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 297-299. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556626</comments>
            <pubDate>Tue, 01 Jul 2008 03:00:53 +0100</pubDate>
            <guid isPermaLink="false">1556626</guid>        </item>
        <item>
            <title>Universal HIV care: a progress report</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.313?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 313-317. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556629</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:07 +0100</pubDate>
            <guid isPermaLink="false">1556629</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.393?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 393-393. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556637</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:06 +0100</pubDate>
            <guid isPermaLink="false">1556637</guid>        </item>
        <item>
            <title>Cytotoxic T lymphocyte responses in HIV-1-infected long-term nonprogressors: lessons for vaccine design</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.351?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 351-361. 
		
	 Cytotoxic T lymphocytes (CTLs) are considered to play an important role in the containment of HIV-1 infection. Their efficacy is, however, limited as they also continuously select for HIV-1 variants with escape mutations in CTL epitopes. Moreover, it ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556634</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:06 +0100</pubDate>
            <guid isPermaLink="false">1556634</guid>        </item>
        <item>
            <title>HIV-1 Tat implicated as a key factor in viral spread</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.323?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 323-326. 
		
	 Evaluation of: Sahaf B, Atkuri K, Heydari K et al.: Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc. Natl Acad. Sci. USA 105, 5111–5116 (2008). Following HIV-1 infection, Tat is amongst ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556631</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:05 +0100</pubDate>
            <guid isPermaLink="false">1556631</guid>        </item>
        <item>
            <title>How the complete sequencing of the domestic cat genome can benefit basic AIDS research</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.301?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 301-307. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556627</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:05 +0100</pubDate>
            <guid isPermaLink="false">1556627</guid>        </item>
        <item>
            <title>Oxidative stress and HIV infection: target pathways for novel therapies?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.327?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 327-338. 
		
	 Oxidative stress is thought to play an important role in the progression of HIV infection. fact, it has been observed that perturbations in antioxidant defense systems, and consequently redox imbalance, are present in many tissues of HIV-infected ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556632</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:04 +0100</pubDate>
            <guid isPermaLink="false">1556632</guid>        </item>
        <item>
            <title>Different disease progression rate according to HIV-1 subtype</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.319?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 319-322. 
		
	 Evaluation of: Kiwanuka N, Laeyendecker O, Robb M et al.: Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J. Infect. Dis. 97, 707–713 (2008). HIV-1 ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556630</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:04 +0100</pubDate>
            <guid isPermaLink="false">1556630</guid>        </item>
        <item>
            <title>Transcriptional gene silencing as a genetic therapy for HIV-1</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.339?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 339-349. 
		
	 The discovery of RNA interference (RNAi) has resulted in a new class of biological agents that can specifically downmodulate HIV-1 gene expression. Delivery of these RNAi-based agents and the emergence of viral resistance present pressing issues in the ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556633</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:03 +0100</pubDate>
            <guid isPermaLink="false">1556633</guid>        </item>
        <item>
            <title>Of mice and monkeys: new advances in animal models to study HIV-1 therapy and prophylaxis</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.363?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 363-373. 
		
	 One of the most significant contemporary challenges in combating HIV-1 infection is the persistence of the virus in infected persons despite potent antiretroviral therapy. Uncovering the requirements for HIV-1 persistence and the development of antiviral ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556635</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:01 +0100</pubDate>
            <guid isPermaLink="false">1556635</guid>        </item>
        <item>
            <title>Modeling HIV infection dynamics: the role of recombination in the development of drug resistance</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.375?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 375-388. 
		
	 The benefit of recombination to HIV remains unclear because just as recombination can induce the association of favorable mutations and accelerate the development of multidrug resistance, it can also dissociate favorable combinations of mutations. The ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556636</comments>
            <pubDate>Mon, 30 Jun 2008 15:10:00 +0100</pubDate>
            <guid isPermaLink="false">1556636</guid>        </item>
        <item>
            <title>Back to the basics: deworming HIV-1-infected individuals</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.4.309?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , July 2008, Vol. 2, No. 4, Pages 309-311. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556628</comments>
            <pubDate>Mon, 30 Jun 2008 15:09:59 +0100</pubDate>
            <guid isPermaLink="false">1556628</guid>        </item>
        <item>
            <title>Male circumcision is not the HIV ‘vaccine’ we have been waiting for!</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.193?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 193-199. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427121</comments>
            <pubDate>Wed, 07 May 2008 03:00:55 +0100</pubDate>
            <guid isPermaLink="false">1427121</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.295?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 295-295. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427133</comments>
            <pubDate>Tue, 06 May 2008 14:01:05 +0100</pubDate>
            <guid isPermaLink="false">1427133</guid>        </item>
        <item>
            <title>When should antiretroviral therapy be started for HIV-infected infants in resource-limited settings?</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.201?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 201-208. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427122</comments>
            <pubDate>Tue, 06 May 2008 14:01:04 +0100</pubDate>
            <guid isPermaLink="false">1427122</guid>        </item>
        <item>
            <title>The POWER and TITAN trials: darunavir/ritonavir in the management of HIV-infected patients</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.229?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 229-245. 
		
	 Darunavir is a new protease inhibitor (PI) active against wild-type and drug-resistant HIV-1 strains and has recently been approved for use in treatment-experienced adult patients. The main clinical trials, POWER and TITAN, have been conducted in ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427126</comments>
            <pubDate>Tue, 06 May 2008 14:01:03 +0100</pubDate>
            <guid isPermaLink="false">1427126</guid>        </item>
        <item>
            <title>Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: implications and solutions</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.263?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 263-270. 
		
	 Antiretroviral therapy (ART) for HIV infection is increasingly being used in resource-poor countries. This has resulted in substantial improvements in the health and life expectancy of HIV patients in these countries, mainly as a result of immune ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427130</comments>
            <pubDate>Tue, 06 May 2008 14:01:02 +0100</pubDate>
            <guid isPermaLink="false">1427130</guid>        </item>
        <item>
            <title>Genes and screens: the search for novel chemotherapeutic targets</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.259?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 259-261. 
		
	 Evaluation of: Brass AL, Dykxhoorn DM, Benita Y et al.: Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921–926 (2008). HIV, like all viruses, must hijack critical cellular machinery in a bid ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427129</comments>
            <pubDate>Tue, 06 May 2008 14:01:02 +0100</pubDate>
            <guid isPermaLink="false">1427129</guid>        </item>
        <item>
            <title>SOCS1: a host factor required for HIV-1 Gag trafficking</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.247?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 247-251. 
		
	 Evaluation of: Ryo A, Tsurutani N, Ohba K et al.: SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl Acad. Sci. USA 105, 294–299 (2008). Gag is an essential HIV ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427127</comments>
            <pubDate>Tue, 06 May 2008 14:01:01 +0100</pubDate>
            <guid isPermaLink="false">1427127</guid>        </item>
        <item>
            <title>Developing HIV-1 vaccines with a positive attitude</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.213?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 213-216. 
		
	 Dr Tomáš Hanke started his undergraduate studies at the Charles University (Prague, Czechoslovakia) reading Chemistry. In 1984, he left as a political refugee to continue his education in Canada, where he completed his BSc degree in Honours Biochemistry ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427124</comments>
            <pubDate>Tue, 06 May 2008 14:01:01 +0100</pubDate>
            <guid isPermaLink="false">1427124</guid>        </item>
        <item>
            <title>Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.271?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 271-280. 
		
	 Important advances have been made in recent years in identifying the molecular mechanisms of HIV neuropathogenesis. Defining the pathways leading to HIV dementia has created an opportunity to therapeutically target many steps in the pathogenic process. ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427131</comments>
            <pubDate>Tue, 06 May 2008 14:01:00 +0100</pubDate>
            <guid isPermaLink="false">1427131</guid>        </item>
        <item>
            <title>Carbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.253?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 253-257. 
		
	 Evaluation of: Pollicita M, Schols D, Aquaro S et al.: Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4 +... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427128</comments>
            <pubDate>Tue, 06 May 2008 14:01:00 +0100</pubDate>
            <guid isPermaLink="false">1427128</guid>        </item>
        <item>
            <title>Role of miRNA in HIV-1 latency</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.281?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 281-290. 
		
	 Postintegration latency of HIV-1 is achieved when host cells contain integrated provirus but viral particles are not being produced. When the cells are activated, infectious viruses can be produced from the cells. Latent infection is one of the important ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427132</comments>
            <pubDate>Tue, 06 May 2008 14:00:59 +0100</pubDate>
            <guid isPermaLink="false">1427132</guid>        </item>
        <item>
            <title>Raltegravir: opening the road for integrase inhibitors in clinical practice</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.217?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 217-227. 
		
	 In the developed world, access to highly active antiretroviral therapy has led to a significant reduction in morbidity and mortality attributed to HIV/AIDS. However, the continual emergence of resistant HIV-1 strains and the limitations of currently ... (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427125</comments>
            <pubDate>Tue, 06 May 2008 14:00:59 +0100</pubDate>
            <guid isPermaLink="false">1427125</guid>        </item>
        <item>
            <title>US pledges billions to fight AIDS</title>
            <link>http://www.futuremedicine.com/doi/abs/10.2217/17469600.2.3.209?ai=61u&amp;mi=2yyy&amp;af=R</link>
            <description>Future HIV Therapy , May 2008, Vol. 2, No. 3, Pages 209-211. (Source: Future HIV Therapy)</description>
            <author>Future HIV Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1427123</comments>
            <pubDate>Tue, 06 May 2008 14:00:58 +0100</pubDate>
            <guid isPermaLink="false">1427123</guid>        </item>
    </channel>
</rss>

